On March 16, 2022 Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, reported that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Forum. Nick Green, president and chief executive officer of Avid Bioservices, will be the featured speaker in a fireside chat at the conference, which will take place March 22-23, 2022 in a virtual format (Press release, Avid Bioservices, MAR 16, 2022, View Source [SID1234610164]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the company’s participation are as follows:
KeyBanc Capital Markets Life Sciences & MedTech Forum
Conference Date: March 22-23, 2022
Fireside Chat Time/Date: 1:30 – 2:05 p.m. Eastern on Wednesday, March 23, 2022
Format: Virtual Conference; webcast available
To listen to the live webcast of the KeyBanc fireside chat, or access the archived webcast, please visit: View Source